Spear Matthew A. 4
4 · Poseida Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Spear Matthew A.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-17$1.32/sh+5,000$6,610→ 21,485 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-17−5,000→ 114,861 totalExercise: $1.32Exp: 2026-06-19→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The stock option is fully vested and exercisable.